Emerald Development Managers

About The Fund

Emerald Development Managers is an early-stage growth equity investment firm focused on backing exceptional scientific and engineering teams who are developing solutions to real-world problems. With headquarters in New York, New York, they target companies in a variety of sectors including life sciences, enterprise software, cybersecurity, industrial technology, and sustainability. Emerald has an investment range starting with a minimum of $100,000, reaching up to a maximum of $5,000,000, and with a sweet spot investment value of around $1,500,000. They specialize in early and seed-stage investments, including Series A rounds. Their geographical focus includes Latin America, highlighting their broadened horizon of investment opportunities. True to their name, Emerald Development Managers invests in people and ideas, partnering with entrepreneurs capable of identifying trends, unearthing needs, and developing brilliant solutions. They offer more than just capital, providing expertise and dedicating time to aid great ideas evolve into the marketplace. Their strategic approach involves taking a long-term view and helping early-stage founders chart a strategic course towards profitability, broader market share, and sustained company growth. Their portfolio showcases a diverse range of investments indicative of a balanced hand in selecting companies with transformative potential. Companies range across various industries, from the owner/operator of the largest salt mine in the U.S. to health technology firms offering groundbreaking blood testing technology, and cybersecurity enterprises pioneering comprehensive protection services. They further express their commitment to innovation and development by participating in sectors like clean technology, biomechanics, and psychoactive medicines aimed at treating neuropsychiatric diseases. As Emerald Development Managers continues to invest, they build upon a track record of fostering groundbreaking companies aiming to not only succeed commercially but also to address the pressing challenges of our day.